Equity &Integration &Procurement Supply Management Bill Brieger | 27 Oct 2010
Health Posts – meeting rural needs
People living in rugged rural terrain often go without formal health services. The population may be remote and even migratory, as some herd cattle.
Angola is working to ensure that at minimum there are Health Posts staffed by trained nurses to provide services beyond the municipal/district headquarters. And since onchocerciasis is common in many of such areas, we are also talking about providing integrated disease control and health care ‘beyond the end of the road,’ as advocated by the African Program for Onchocerciasis Control.
Life for these nurses is not easy as there is usually just one staff member to run the post. Also this situation means that male nurses predominate – one reason why it is presumed that antenatal care may not be easy to provide.
A visit to such a health post recently showed that not only was the nurse enthusiastic, but that he could provide some of the basic components of antenatal care in all but name.
The post had a good supply of sulphadoxine-pyramethamine that is required for intermittent preventive treatment of malaria in pregnant women. There were other medicines and supplements routinely given pregnant women such as ferrous sulfate and de-worming drugs. The nurse even had a fetal stethoscope.
Strengthening these rural outposts is a priority for malaria control and health equity. These rural populations do not even have access to medicine shops as found in some areas.
Regular supplies of nets, RDTs, ACTs and SP will guarantee that all parts of Africa can work toward reducing malaria deaths by 2015.
Funding &Partnership &Procurement Supply Management Bill Brieger | 08 Oct 2010
GAPS – funding, oversight and participation
AIDSPAN has produced another valuable issue of the Global Fund Observer (GFO) that reports and analyzes the challenges of implementing Global Fund grants. Three of the main articles address serious gaps in various areas of programming.
The first gap is one of funding. As we discussed recently, even with an overall increase in pledges to the GFATM, the amounts are inadequate to achieve goals. The inability to raise funds at all level shows serious weaknesses in commitment and planning. AIDSPAN notes consequences of this such that for example …
In fact, though, this week’s pledges provide only $2.9 billion for Rounds 10, 11 and 12. The current estimate of the cost of Phase 1 of Round 10 is $2.0 billion. So the prospects for adequately funding Rounds 11 and 12, and Phase 2 of Round 10, are currently bleak, unless funds significantly in excess of this week’s pledges end up being raised.
The second gap is in oversight of procurement and supply management (PSM). “Deficiencies in the oversight of procurement and supply management (PSM) arrangements may be exposing Global Fund grants to unnecessary and unacceptable risks. This is one of the conclusions of an audit report released by the Fund’s Office of the Inspector General (OIG) in April 2010.”
Some of the main PSM deficiencies as summarized by GFO are –
- weak forecasting of requirements for drugs and health product
- weak technical specifications for procurement
- absence of, or weak, procurement policies and procedures
- poor inventory management
- poor storage and transportation facilities at national and sub-national level
- weak procurement planning resulting in frequent emergency procurements and
- inadequate management information systems
The third major gap reported in the GFO is lack of civil society participation in County Coordinating Mechanisms (CCMs) for global fund grants. The article highlights the Civil Society Action Team’s recent report. This report documented the fact that while persons affected by the three diseases in theory have representation on CCMs, they often do not take part in the real decision making.
In particular, “civil society representatives often lack the capacity and expertise to fully engage in CCM processes and to properly represent their constituents.” Lack of participation threatens the relevance and acceptability of programs.
These gaps focus on weaknesses basic health systems management processes and competencies. It is not enough to point out these gaps. Serious efforts are needed to strengthen health systems. Unless these three gaps are closed, partner interest in pursuing the noble goals of disease control and elimination will be threatened.
Efficacy &Health Systems &Procurement Supply Management Bill Brieger | 26 Sep 2010
What if available malaria tools actually reached people?
Tachi Yamada of the Gates Foundation told Discover Magazine (October 2010) that, “… childhood deaths … could fall by half by 2025 if we could deliver existing vaccines, malaria treatment, and today’s other lifesaving tools with 90% penetration to those at risk.†During the push towards Universal Coverage, it is good to ask whether we can really reach people with our existing tools.
The INDEPTH Effectiveness and Safety Studies (INESS) offers a conceptual model as to what happens when a when efforts are made to ensure that a highly efficacious tool – malaria medicines, LLINs – actually reaches people. This ultimately impacts on the effectiveness of the tool. Thus a drug that is 95% efficacious, may be less than 50% effective if the right people do not take it at the tight time.
First people need access to the tool – in the INESS case ACTs. We must deal with all the procurement and supply chain management issues that determine whether the medicines will reach the sick people in good condition beyond the end of the tarmac road. Then targeting must be considered – do the right people get the medicines? Next the health workers themselves must comply with treatment guidelines, and finally, if the person with malaria gets his/her drugs, will he/she adhere to the treatment regimen?
Peter Moszynski in the British Medical Journal also expresses concern about the access and compliance issues:
Despite the widespread availability of effective new (malaria) drugs and diagnostic tools … major problems remain. Issues such as misdiagnosis and overprescription of treatments, counterfeit drugs, problems in supply and delivery, and emerging resistance to drugs “all hamper effective treatment.” A lack of awareness among donors and the public of some these basic problems “threaten the success of global malaria control efforts.“
Beatrice Wasunna, et al. addressed the provider compliance issue when they found that, “In-service training and provision of job aids alone may not be adequate to improve the prescribing, dispensing and counseling tasks necessary to change malaria case-management practices and the inclusion of supervision and post-training follow-up should be considered in future clinical practice change initiatives.”
Many resources are flowing through health systems right now, especially with the pressure to achieve Universal Coverage and the enthusiasm generated by the MDG Summit. Can we ensure that the health systems in place can bring the effectiveness of these tools closer to their actual scientifically tested efficacy?
Private Sector &Procurement Supply Management Bill Brieger | 08 Sep 2010
Diversions – bumps in the road to malaria elimination
During visits to private pharmacies in 11 African cities from late 2007 to early 2010 Bate and colleagues purchased 894 samples of antimalarial medicines. Overall 6.5% of these medicines had evidence of being diverted from the public health system. This was only 4.2% of the older malaria therapies, but 27.8% of the 151 ACTs had come from the public sector.
The ACT diversion problem was most noticeable in Nairobi, Lagos, Kampala, Luanda and Dar es Salaam. The photo here shows ACTs we found in a small pharmacy shop down the street from a clinic in the suburbs of Luanda in 2008. Informal discussions in Luanda with donors also revealed major problems of theft from the ports. Specifically, the Boston Globe reported that, “According to an audit last year by the US President’s Malaria Initiative, about $640,000 worth of medicines sent to Angola vanished from airports and the government’s medicines warehouse.”
The authors are the first to admit that the study design is not perfect and that their sample size could have been larger, but the key issue is that they have actually documented the ‘leakage’ of these donated medicines from the people who need them. This moves the problem beyond the anecdotal level.
Medicines are not the only area where the diversion makes malaria commodities take a detour. Nets disappear, too.
Last year’s universal LLIN distribution in Kano State, Nigeria experienced some challenges in terms of reaching people and their retaining nets. The goal was two nets per household, but a report by donors after the distribution found that 28% of households surveyed got only one. Seven percent of nets that reached households were also ‘lost’. So far there have been no mechanisms like the study by Bates and colleagues to trace nets into the private sector or elsewhere.
The main issue we see is that health systems need to be strengthened and public education needs to be improved – in this was diversions will be less likely and the public can serve as a watchdog for any malpractices and take an active role in rolling back malaria in their communities.
*************************
ps –
By Tiemoko Diallo BAMAKO, Sept 8 (Reuters) - Mali has arrested seven Health Ministry workers for embezzling hundreds of thousands of dollars in aid meant to combat malaria and other diseases, a senior ministry official said on Wednesday. The case could threaten international aid flows into the West African country which is seeking additional support from donors ...
Procurement Supply Management Bill Brieger | 30 Aug 2010
Infrastructure needed for economic growth … and health
Dr Ngozi Okonjo-Iweala, the World Bank managing director, addressed the need for well functioning transport and trade facilitation to boost economic growth. She was quoted in the Monitor as adding that, “You can’t trade without the means to get goods offshore.”
Concerning Africa, Dr Okonjo-Iweala explained that …
We know better logistics are strongly associated with trade expansion, export diversification, the ability to attract foreign direct investments, and economic growth. Yet the 2010 Logistics Performance Indicators (see figure to right) showed that Sub-Saharan Africa is home to the 10 lowest performing countries in the survey. This is a cause for concern. Simplified customs and export procedures to quickly move goods across borders are also important. Yet the World Bank Group’s latest Doing Business report indicates that the average number of days to export from sub-Saharan Africa is 33. This can range from 75 days in Chad, 37 days in Uganda, and 23 in Mozambique.
While these infrastructural weaknesses hinder export and trade, they also hinder procurement and supply management for importing and distributing malaria commodities needed to meet Roll Back Malaria and Millennium Development Goals.
According to Roll Back Malaria, “Controlling malaria through universal coverage is not only about increasing spending and the delivery of malaria interventions. It also requires building, expanding and continuously improving health systems supporting all interventions.” This includes infrastructure such as transport, logistics, and communication.
The ongoing national LLIN distribution effort in Nigeria has been able to document some of the logistical challenges facing malaria program roll out efforts. In one state the reconciliation of LLINs supplied and those received at local government level delayed the implementation of the campaign. A ship containing nets balance had arrived at Lagos port however, due to congestion had not docked. Imbalance in LLINs supplied to local governments required shifting of supplies.
Logistics innovations to address such problems in Nigeria included training staff in use of waybills and stock sheets to help track LLINs. Another helpful factor was identification of appropriate storage facilities in all local governments.
Malaria No More and partners recently conducted Logistics Training to help countries learn from challenges and best practices, like seen in the Nigerian experience. Some of the key steps in Logistics planning that were outlined in the training include –
- Customs clearances (selection of agent, Tax/Vat exoneration)
- Security (personnel, transport and storage)
- Storage (calculate storage volume, storage plan), negotiate with local government, partners and area facilities, physical location and accessibility
- Transport (based on strategy) transport from entry points to the districts (macro) and from district to DPs (micro), identity available resources, develop transport plan
- Micro-planning logistics (micro-planning guide document)
- Tools and control mechanisms and follow-up of the LLINs (tracking)
- Standardized templates in planning (storage, transport,budgets)
Infrastructure improvements will enhance economic growth and enable families in the long term to afford malaria prevention and treatment, but right now, extra effort is needed to overcome infrastructural and logistics challenges to Universal Coverage so that a healthier, malaria-free populations can contribute to their nations’ growth.
Epidemiology &Integrated Vector Management &Procurement Supply Management Bill Brieger | 22 Feb 2010
Malaria – tis the season
In many parts of the tropical world malaria is seasonal, depending in large part upon rains. If taken into account, seasonality can allow malaria program managers to plan better to serve different areas of their countries. There are areas where a dry season or colder weather may appear to put a stop to transmission completely, but often minimal transmission manages to take place.
When we know that some areas have more intense malaria transmission during certain times of year, we can ensure that our interventions are in place well in advance of major rains. Knowledge of seasonality can guide vector control efforts and help plan for increased stocks of medicines and diagnostic tests in clinics, for example. Several examples of the need for such preparations have been in the news this weekend.
Malaria’s Day in Court
In India the Kolkata Municipal Corporation is apparently under legal investigation for inadequate supplies of malaria medicines in clinics in Bhowanipore, which is a malaria-prone area. In a bid to find out what he needed to do, a medical officer unknowingly broke protocol and visited the judge hearing the case to get advice on how better to serve the people of the area.
Fortunately he was not reprimanded for his efforts to get ahead of impending malaria outbreaks.
Awaiting the Storm
Adding to Haiti’s existing medical chaos and suffering is the season of increasing rains. People are still living in makeshift tents that given no protection when it comes to mosquitoes and malaria.
The Boston Globe reports that, “Some rain typically falls every month in Haiti, meteorologists say, but heavy downpours could begin as early as this month.â€Â As seen in the satellite photo from NOAA, Haiti was in the path of several major hurricanes and tropical storms in 2008 – so rains from these storms kill people directly through flooding, and those who survive can expect to be threatened with malaria.
Interfaith Preparation
Nigeria accounts for at least one-fourth of the malaria deaths in Africa, according to AFP. A major national net distribution is underway, which will hopefully make major inroads before the heavy rains start.
Planning is the key – we must understand the malaria transmission patterns in our countries and plan to get the material and human resources in place in a timely manner so that they will be effective in bringing down malaria morbidity and mortality.
Procurement Supply Management Bill Brieger | 26 Jan 2010
Fueling malaria control
Nigeria with at least 140 million citizens living in high malaria transmission areas appears to have the highest burden of the disease in the world. Global progress towards malaria elimination depends on Nigeria’s progress. Yet the 2008 Nigeria Demographic and Health Survey (DHS) shows indicators falling below the targets set for 2005, and therefore well below what was hoped for in 2010 (80% coverage of malaria interventions).
- 16.9% of households have at least one bednet of any kind (16.3% are ITNs)
- 11.9% of children aged <5years had slept under any net (5.5% under ITNs)
- 11.8% of pregnant women had slept under any net (4.8% under ITNs)
- 4.9% of pregnant women had received 2 doses of IPT
- 33.2% of children with suspected malaria took an anti-malarial drug (15.2% got that treatment the same day; 2.4% got an ACT)
Nigeria certainly does not lack resources for malaria control, either from its extensive earnings from the oil industry or from international programs like the Global Fund. What then explains the difficulty in achieving malaria targets?
One possible reason can be found in a This Day newspaper whose editorial …
Like a monster that cannot be tamed fuel scarcity in Nigeria seems to have come to stay. What makes this national disaster and embarrassment even more unfortunate is government’s glaring inability to tackle a most basic need of the country. No doubt, this ignoble path, if not arrested, would lead the nation to more desperate social and economic consequences.
Several reasons are proffered for the fuel dilema, but in the end, according to the editorial, “… this country does not have to remain a theatre of winding queues and protracted traffic jams at filling stations. Neither do its citizens deserve to live fuel scarcity – induced mediocre lives. In the absence of respectable energy sources, people have continued to be subjected to all kinds of trauma.”
Part of the trauma is lack of malaria commodities – nets, medicines – at the front line where children are dying from the disease. Supply chains, whether in the public or private sector are threatened, and prices increase with scarcity. Provision of supervision and technical assistance from national to state to local government to front line health facility and return of timely data in the other direction is thwarted when there is no fuel.
Nigeria may not be able to eliminate malaria until it can eliminate fuel shortages.
Drug Quality &Procurement Supply Management &Treatment Bill Brieger | 19 Jan 2010
Putting a gift horse in the mouth
The old saying goes, ‘don’t look a gift horse in the mouth.’ Equine experts can tell a lot about the age, health and travails of a horse by examining the teeth and mouth. The admonition not to examine an animal that is a gift might arise from not wanting to embarrass the giver, and why worry anyway if you did not pay for the horse.
It may me another matter when the intended gift is to be swallowed.
News reports record that, “The Chinese government on Monday (18 January 2010) donated over 244,000 doses of anti-malarial drugs to the Uganda in a bid to fight the deadly disease that kills over 320 people daily in the East African country.” The donation includes 144,000 doses of Arco and 100,000 doses of Duo-Cotexin.
Supplies of the same two drugs were also donated by China in April 2009. The two medicines apparently are not yet included in the country’s essential medicine list or listed as firstline treatments in the national malaria strategy/policy. “The drugs are, however, still awaiting pre-qualification from the World Health Organisation (WHO).”
Duo-Cotexin is a dihydroartemisinin plus piperaquine product (of which other brands include Artekin, Artecom, CV8) and is “given in a four-dose regimen that has proved highly effective and well tolerated in South East Asian trials.” ARCO is a combination of two drugs – Artemisin and Naphthoquine Phosphate. At present the only two combinations that have WHO pre-qualified products are Artemether+Lumefantrine (AL) and Amodiaquine+Artesunate (AA). AL is the firstline treatment used in Uganda.
The two donated drugs apparently do offer a more convenient regimen than AL, which is taken for 3 days. “For Arco, its dose is swallowed once while Duo-Cotexin the tablets are swallowed once a day as prescribed by a doctor.”
The main concern is that when there are many different types of drugs on the shelves with different regimens, as is the case here, health workers and patients can get confused. There may also be different formulations for different age groups.
Granted, Uganda has not often had the luxury of too many malaria drugs, and shortages have been common. Thus, there may be the tendency not to look this gift horse (or medicine) in the mouth. Uganda, like most endemic countries, is definitely under pressure to scale up for impact this year.
We can only encourage the malaria partners in Uganda to practice pharmaco-vigilance with these donations and ensure thorough in-service education for health staff and patient education to promote adherence among clients.
Performance &Procurement Supply Management Bill Brieger | 23 Dec 2009
Procurement bottlenecks – whose fault and can they be fixed?
Roger Bate and colleagues (Tren, Hess and Bate, 2009) are again challenging us to face up to problems with the procurement, supply and quality of malaria control medicines and commodities. Their article that appeared yesterday in Malaria Journal questions whether efforts to get supplies from the lowest price bidder pay off in the end.
Kenya and the Global Fund are the major focus of this analysis. Kenya’s Round 4 Malaria grant from GFATM has not had easy sailing and currently is rated at B2 – which means “Inadequate but potential demonstrated.” The grantee was plagued with considerable procurement and supply management (PSM) problems during Phase 1, when the Global Fund observed that, “Overall performance of this program has not been satisfactory to date.”
Prior to receiving approval for Phase 2 the Fund did note change: “The PR (had) considerably improved the PSM plan which was a CP (Conditions Precedent) for this disbursement and overall the revisions to the PSM plan address the majority of concerns raised at Phase 2 signature.” An innovation at address PSM was a ‘procurement consortium’ that would enable the Kenyan program to collaborate with experienced agencies and learn. An observation by Amin et al., shows how this process was complicated by the way the Round 4 Malaria grant was set up initially.
The main challenge centered on how to manage the financial flows to make sure funds were availed in time for orders to be placed and processed. Theoretically, funds would flow from the GFATM, to the principal recipient (Ministry of Finance), then to the MoH (sub-recipient). The MoH would, after consultation with the national procurement consortium established to manage the tendering and ordering of commodities purchased with GFATM funds, place an order with WHO to forward the order to the supplier (Novartis Pharma AG in Switzerland).
This lengthy process was also highlighted by the Global Fund. “The PR (principal recipient) should also disburse directly to the Consortium, rather than through SRs (sub-recipients), in order to avoid excess bureaucracy and speed up the procurement cycle.”
The specific concern of Tren et al., is a recent effort by the Global Fund to ask some grant recipients to use international competitive bidding processes for certain drug purchases. In the case of Kenya “After awarding the tender for its annual supply of the anti-malarial artemether-lumefantrine to the lowest bidder, Ajanta Pharma, Kenya experienced wide stock-outs in part due to the company’s inability to supply the order in full and on time.”
The Global Fund itself states that, “The central objective of Global Fund procurement policies is to procure quality-assured products at the lowest price and in accordance with national and international law. Procurement must be conducted in a transparent fashion.” ‘Competitive procurement’ is mentioned in these guidelines, and WHO’s pre-qualification process for ensuring drug quality is stressed, though as Tren et al., point out, exceptions to the latter can be made.
Back to Kenya – Tren et al. have shown that delays in procurement have occurred with the Ajanta contract starting in 2008, but delays and stock-outs have been a common occurrence since the start of Global Fund malaria programming in Kenya.
One of the major procurement delays and inefficiencies, sending money into a country, converting it to local currency and then procuring from an outside source requiring re-conversion of the money, has been addressed partially by GFATM’s Voluntary Pooled Procurement (VPP). It was hoped that the labyrinthine procurement process among PRs, SRs and others in Kenya could have been ameliorated by VPP, but apparently this was not to be.
In the meantime Kenya has been turned down by the GFATM for all subsequent malaria grant applications since Round 4, in part due to poor performance linked with these procurement challenges. Kenya’s only current GFATM malaria grant expires in less than 14 months. Somebody better get the procurement process right before then.
Funding &Procurement Supply Management Bill Brieger | 15 Dec 2009
Sierra Leone – malaria emergency
The United Nations’ humanitarian news agency, IRIN, headlines an “Appeal for aid as malaria ’emergency’ looms.” Apparently there has been an upsurge in malaria deaths among children.
IRIN says that WHO and Unicef “are ‘urgently’ appealing for 1.3 million bednets, as well as anti-malaria drugs, at a cost of US$16.9 million. The situation is now considered as constituting a potential emergency,” said their statement. This press release has been reprinted in dozens of sources ranging from news agencies to relief organizations since it appeared a few days ago. How did the situation get this bad?
Sierra Leone is the recipient of two Global Fund malaria grants from Rounds 4 and 7. The Round 4 (R4) grant began on 1st May 2005 and was to run for 5 years. Strangely, the grant has not been approved for Phase 2 funding although Phase 1 funding supposedly ended in April 2007. The most recent progress report for the R4 grant on the Sierra Leone webpage is dated August 2008, and shows only 78% of the Phase 1 money (or 46% of the intended grant total) was disbursed by that point.
By the end of the second year the R4 there seemingly was acceptable progress toward goals of distributing ITNs and providing IPT to pregnant women. But malaria treatment was severely lagging. Overall the grant had been scoring a B2 – “inadequate but potential demonstrated.”
The Round 7 (R7) malaria grant, which began on 1st May 2008, is closing in on its Phase 1 endline. It is also rated B2 and has received 76% of its Phase 1 budget (or 30% of the total planned grant). During the reporting period that ended in May 2009 it appeared that treatment targets for children were being met and malaria drug stockouts were being prevented at facilities, but home/community based treatment goals were falling short. ITN and IPT distribution looked good, but the review of the grant stated …
PR plans to procure ACTs in the first two installments and accelerate activities that were delayed in Year One. The PR has improved significantly performance on the period as well as general management of the grant … We are cautious with our B2 rating due to the weaknesses in procurement/planning which have been identified. This should be resolved in the next progress report …
It may be possible that the R4 grant had been rolled into the R7 grant. In either case, it appears that malaria treatment was the weak link, and yet IRIN reported that, “Only 26 percent of children sleep under treated bednets.” This contrasts with 56% reported on the RBM webpage for Sierra Leone based on 2007 data reported from the National Malaria Control Program.
IRIN mentioned that the WHO-Unicef communique states that, “the approach to malaria in Sierra Leone is still more curative than preventive.” This is ironic given the better reported performance for ITNs and IPTp on both the RBM and GFATM websites and the poor performance for malaria treatment also highlighted on both.
Back to the source – WHO and Unicef representatives in the country were reacting to the following: “An analysis of recent data from the Ministry of Health and Sanitation indicates that over the past four months, there has been a significant increase in the number of children under five dying as a result of malaria.” We are not sure whether these were confirmed through laboratory tests nor whether they represent a normal seasonal rise in the disease.
Like other countries Sierra Leone has been guided by RBM to develop a road map toward achieving universal coverage by December 2010. The road map outlines the following gaps:
- 1.6 million ITNs needed out of a projected requirement of 3.0 million
- 7.7 million ACT doses needed out of 8.5 million
- 1.6 million IPTp doses needed out of 1.7 million
At the same time Sierra Leone reports having US $2.5 million for ACT purchases from PLAN, Global Fund and Unicef to reach 2010 malaria treatment targets, and $11.1 million from all sources to address all interventions by 2010.
Based on the GFATM progress report findings, one wonders whether the ‘emergency‘ is really a procurement problem more than a funding problem. This makes the emergency no less real to people suffering from malaria, but shows that technical assistance to strengthen health systems needs to receive equal attention to funding for commodities.
——————————–
PS – The role of the private sector is not mentioned in the communique even though the Concord Times of Freetown reported in June 2009 that, “The Pharmacy Board of Sierra Leone-PBSL in a bid to make Anti Malaria Drugs more accessible to the vast majority of citizenry, has deregulated the sales of Atesunate (the combination therapy for Malaria treatment) which used to be a prescription drug and could now be sold over the counter and in patent drug stores all over the country.” It also does not acknowledge the role of the corporate and NGO sectors: “Standard Chartered in partnership with the Anglican Diocese -Bo will distribute over 16,000 Insecticide-Treated Nets to different target groups in Pujehun, Bo and Freetown” (October 2009).